Mijung Yim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Iris Koreana NAKAI Inhibits Osteoclast Formation via p38-Mediated Nuclear Factor of Activated T Cells 1 Signaling Pathway.
Journal: Journal of bone metabolism
Published: May 01, 2023
Extracellular Prdx1 mediates bacterial infection and inflammatory bone diseases.
Journal: Life sciences
Published: March 30, 2023
Anti‑osteoclastogenic effects of Coriandrum sativum L. via the NF‑κB and ERK‑mediated NFATc1 signaling pathways.
Journal: Molecular medicine reports
Published: February 22, 2022
The Role of Toll-Like Receptors in Osteoclastogenesis.
Journal: Journal of bone metabolism
Published: September 28, 2020
Dynamin-related protein 1 positively regulates osteoclast differentiation and bone loss.
Journal: FEBS letters
Published: August 01, 2020
FXR/TGR5 mediates inflammasome activation and host resistance to bacterial infection.
Journal: Biochemistry and biophysics reports
Published: May 10, 2020
3',4',7,8-Tetrahydroxyflavone inhibits RANKL-induced osteoclast formation and bone resorption.
Journal: Die Pharmazie
Published: February 15, 2018
Montelukast inhibits RANKL‑induced osteoclast formation and bone loss via CysLTR1 and P2Y12.
Journal: Molecular medicine reports
Published: November 16, 2017
Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways.
Journal: Journal of bone metabolism
Published: August 21, 2017
Attenuation of RANKL-induced Osteoclast Formation via p38-mediated NFATc1 Signaling Pathways by Extract of Euphorbia Lathyris L.
Journal: Journal of bone metabolism
Published: September 30, 2016
F4/80 inhibits osteoclast differentiation via downregulation of nuclear factor of activated T cells, cytoplasmic 1.
Journal: Archives of pharmacal research
Published: August 15, 2016
Last Updated: 09/26/2026